Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000555385 | SCV000643396 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-02-15 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727403 | SCV000708260 | uncertain significance | not provided | 2017-05-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000597681 | SCV000714959 | likely benign | not specified | 2018-03-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Revvity Omics, |
RCV000727403 | SCV003821057 | uncertain significance | not provided | 2023-01-26 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150266 | SCV003837998 | likely benign | Cardiomyopathy | 2022-02-18 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000727403 | SCV001798995 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000727403 | SCV001923485 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000727403 | SCV001975612 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000727403 | SCV002034897 | uncertain significance | not provided | no assertion criteria provided | clinical testing |